论文部分内容阅读
中草药治疗恶性肿瘤的研究,各地均报道过有效的单.验方,并在临床及实验的研究上进行了大量的工作。近几年我们先后观察了术前应用喜树硷、山豆根、断肠草、斑蝥酸钠以及上述中草药加化疗药物治疗后切除标本的病理形态学改变,初步小结过其形态特点。中草药如山豆根、断肠草虽然对癌组织的杀伤作用不如化疗药物强烈,但也有不同程度的退化性改变,突出的是癌周边淋巴样细胞反应增强。认为属增强肿瘤宿主细胞免疫反应型药物,从形态学上证明中草药的“扶正祛邪”作用,为中西医结合治疗恶性肿瘤提供了形态学根据。现将术前应用中草药及加化疗的手术切除食管癌、贲门癌187例标本(食管鳞癌154例,贲门腺癌33例)
Chinese herbal medicine for the treatment of malignant tumors has reported effective single prescriptions throughout the country, and has carried out a large amount of work on clinical and experimental research. In recent years, we have observed the preoperative pathological changes of the resection specimens of Camptotheca acuminata, Shandougen, Gujucao, Cantharidin, and the above herbs plus chemotherapeutic drugs. The preliminary summary has its morphological characteristics. Chinese herbal medicines such as Shandougen and Gujucao have a less severe effect on cancerous tissues than chemotherapy drugs, but they also have varying degrees of degenerative changes, highlighting the enhanced lymphoid cell reaction around the cancer. It is believed that the enhancement of the tumor host cell immune response drug, from the morphological point of view to prove that the Chinese herbal medicine “fighting and eliminating evil” role in the treatment of malignant tumors with Chinese and Western medicine provides a morphological basis. Now 186 cases of esophageal and cardiac cancers were surgically treated with Chinese herbal medicine and chemotherapy before surgery (154 cases of esophageal squamous cell carcinoma and 33 cases of cardia adenocarcinoma).